Compound 61625
Formula Pending
Research Abstract
Thyroid Analog candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61625 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in compassionate use with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061625 with updates logged 2108-05-12.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Nomenclature
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061625
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61625